Biomarker Profiling for Lupus Nephritis

Genomics, Proteomics and Bioinformatics

Volumn 11, Issue 3, 2013, Pages 158-165

  Li, Yajuan ^a,b   Fang, Xiangdong ^b   Li, Quan Zhen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

Biomarker; Epigenetics; Genetics; Lupus nephritis; Protein

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR5; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL PROTEIN C RECEPTOR; ESTROGEN RECEPTOR; FC GAMMA RECEPTOR III A; FC GAMMA RECEPTOR III B; FC RECEPTOR; GAMMA INTERFERON; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR2 ANTIGEN; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGRAMMED DEATH 1 RECEPTOR; STAT4 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UTEROGLOBIN;

BLOOD SAMPLING; COPY NUMBER VARIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC VARIABILITY; GENOMICS; HISTONE MODIFICATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RISK FACTOR; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTOMICS;

ANIMALS; BIOLOGICAL MARKERS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; LUPUS NEPHRITIS; MICRORNAS; POLYMORPHISM, GENETIC; PROTEOME; TRANSCRIPTOME;

EID: 84879779907     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2013.05.003     Document Type: Review

References (81)

1. Cervera R., Abarca-Costalago M., Abramovicz D., Allegri F., Annunziata P., Aydintug A.O., et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus project". Autoimmun Rev 2006, 5:180-186.
2. Gurevitz S.L., Snyder J.A., Wessel E.K., Frey J., Williamson B.A. Systemic lupus erythematosus: a review of the disease and treatment options. Consult Pharm 2013, 28:110-121.
3. Liu C.C., Manzi S., Ahearn J.M. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol 2005, 17:543-549.
4. Marchini M., Antonioli R., Lleo A., Barili M., Caronni M., Origgi L., et al. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 2003, 64:462-468.
5. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
6. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 2009, 18:9-15.
7. Jacob C.O., Zang S., Li L., Ciobanu V., Quismorio F., Mizutani A., et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003, 171:1564-1571.
8. Wakeland E.K., Liu K., Graham R.R., Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15:397-408.
9. Mohan C. Murine lupus genetics: lessons learned. Curr Opin Rheumatol 2001, 13:352-360.
10. Morel L. Genetics of human lupus nephritis. Semin Nephrol 2007, 27:2-11.
11. Lindqvist A.K., Alarcon-Riquelme M.E. The genetics of systemic lupus erythematosus. Scand J Immunol 1999, 50:562-571.
12. Freedman B.I., Spray B.J., Heise E.R., Espeland M.A., Canzanello V.J. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern organ procurement foundation. Am J Kidney Dis 1993, 21:378-382.
13. Manger K., Repp R., Spriewald B.M., Rascu A., Geiger A., Wassmuth R., et al. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum 1998, 41:1181-1189.
14. Koene H.R., Kleijer M., Swaak A.J., Sullivan K.E., Bijl M., Petri M.A., et al. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 1998, 41:1813-1818.
15. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855.
16. Karassa F.B., Trikalinos T.A., Ioannidis J.P. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003, 63:1475-1482.
17. Li L.H., Yuan H., Pan H.F., Li W.X., Li X.P., Ye D.Q. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Scand J Rheumatol 2010, 39:148-154.
18. Bazilio A.P., Viana V.S., Toledo R., Woronik V., Bonfa E., Monteiro R.C. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol Dial Transplant 2004, 19:1427-1431.
19. Teramoto K., Negoro N., Kitamoto K., Iwai T., Iwao H., Okamura M., et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J Pharmacol Sci 2008, 106:56-67.
20. Allam R., Sayyed S.G., Kulkarni O.P., Lichtnekert J., Anders H.J. Mdm2 promotes systemic lupus erythematosus and lupus nephritis. J Am Soc Nephrol 2011, 22:2016-2027.
21. Liu K., Li Q.Z., Delgado-Vega A.M., Abelson A.K., Sanchez E., Kelly J.A., et al. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 2009, 119:911-923.
22. Li Q.Z., Zhou J., Yang R., Yan M., Ye Q., Liu K., et al. The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis. Genes Immun 2009, 10:503-508.
23. Shao X., Yang R., Yan M., Li Y., Du Y., Raman I., et al. Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis. Arthritis Rheum 2013, 65:780-791.
24. Prokunina L., Gunnarsson I., Sturfelt G., Truedsson L., Seligman V.A., Olson J.L., et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004, 50:327-328.
25. Jonsen A., Gunnarsson I., Gullstrand B., Svenungsson E., Bengtsson A.A., Nived O., et al. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford) 2007, 46:1417-1421.
26. Parsa A., Lovett D.H., Peden E.A., Zhu L., Seldin M.F., Criswell L.A. Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis. Genes Immun 2005, 6:217-224.
27. Sprovieri S.R., Sens Y.A., Martini Filho D. Association between polymorphisms of the renin-angiotensin system and more severe histological forms of lupus nephritis. Clin Nephrol 2005, 64:20-27.
28. Zhou T.B., Liu Y.G., Lin N., Qin Y.H., Huang K., Shao M.B., et al. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 2012, 39:686-693.
29. Malafronte P., Vieira J.M., Pereira A.C., Krieger J.E., Barros R.T., Woronik V. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. J Rheumatol 2010, 37:776-782.
30. Yang W., Zhao M., Hirankarn N., Lau C.S., Mok C.C., Chan T.M., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 2009, 18:2063-2070.
31. Rovin B.H., Lu L., Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002, 62:261-265.
32. Wang A.Y., Poon P., Lai F.M., Yu L., Choi P.C., Lui S.F., et al. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Kidney Int 2001, 59:1520-1528.
33. Lee Y.H., Kim H.J., Rho Y.H., Choi S.J., Ji J.D., Song G.G. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus 2004, 13:188-191.
34. Sesin C., Yin X., Buyon J.P., Clancy R. In vivo and in vitro evidence that shedding of endothelial protein C receptors (EPCR) contributes to the pathogenesis of SLE. Arthritis Rheum 2004, 50:647.
35. Aguilar F., Nunez-Roldan A., Torres B., Wichmann I., Sanchez-Roman J., Gonzalez-Escribano M.F. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J Rheumatol 2003, 30:1770-1774.
36. Forton A.C., Petri M.A., Goldman D., Sullivan K.E. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 2002, 19:459.
37. Liu Z.H., Cheng Z.H., Gong R.J., Liu H., Liu D., Li L.S. Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron 2002, 90:174-180.
38. Villarreal J., Crosdale D., Ollier W., Hajeer A., Thomson W., Ordi J., et al. Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients. Rheumatology (Oxford) 2001, 40:1009-1012.
39. Menegatti E., Nardacchione A., Alpa M., Agnes C., Rossi D., Chiara M., et al. Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. Lab Invest 2002, 82:543-546.
40. Miyake K., Nakashima H., Akahoshi M., Inoue Y., Nagano S., Tanaka Y., et al. Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology (Oxford) 2002, 41:518-524.
41. Renaudineau Y., Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 2011, 60:10-16.
42. Zouali M. Epigenetics in lupus. Ann N Y Acad Sci 2011, 1217:154-165.
43. Hedrich C.M., Tsokos G.C. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 2011, 17:714-724.
44. + lupus T cells. J Immunol 2004, 172:3652-3661.
45. Sunahori K., Juang Y.T., Kyttaris V.C., Tsokos G.C. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol 2011, 186:4508-4517.
46. Wen Z.K., Xu W., Xu L., Cao Q.H., Wang Y., Chu Y.W., et al. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 2007, 46:1796-1803.
47. Garaud S., Le Dantec C., Jousse-Joulin S., Hanrotel-Saliou C., Saraux A., Mageed R.A., et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009, 182:5623-5632.
48. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
49. Nowling T.K., Gilkeson G.S. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011, 13:250.
50. Dieker J.W., Fransen J.H., van Bavel C.C., Briand J.P., Jacobs C.W., Muller S., et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 2007, 56:1921-1933.
51. Mishra N., Reilly C.M., Brown D.R., Ruiz P., Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 2003, 111:539-552.
52. Hu N., Long H., Zhao M., Yin H., Lu Q. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand J Rheumatol 2009, 38:464-471.
53. WAF1/Cip1 expression. Arthritis Rheum 2004, 50:3365-3376.
54. Carlsen A.L., Schetter A.J., Nielsen C.T., Lood C., Knudsen S., Voss A., et al. Circulating MicroRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 2013, 65:1324-1334.
55. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009, 29:749-754.
56. Lu J., Kwan B.C., Lai F.M., Tam L.S., Li E.K., Chow K.M., et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012, 17:346-351.
57. Te J.L., Dozmorov I.M., Guthridge J.M., Nguyen K.L., Cavett J.W., Kelly J.A., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5:e10344.
58. Guan J., Wang G., Tam L.S., Kwan B.C., Li E.K., Chow K.M., et al. Urinary sediment ICAM-1 level in lupus nephritis. Lupus 2012, 21:1190-1195.
59. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010, 10:3-7.
60. Ullal A.J., Reich C.F., Clowse M., Criscione-Schreiber L.G., Tochacek M., Monestier M., et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 2011, 36:173-180.
61. Bizzaro N., Villalta D., Giavarina D., Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? a systematic review and a study of metanalysis. Autoimmun Rev 2012, 12:97-106.
62. Chen Z., Wang G.S., Wang G.H., Li X.P. Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis. Clin Rheumatol 2012, 31:1323-1329.
63. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 2005, 115:3428-3439.
64. Li Q.Z., Zhou J., Wandstrat A.E., Carr-Johnson F., Branch V., Karp D.R., et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 2007, 147:60-70.
65. Treamtrakanpon W., Tantivitayakul P., Benjachat T., Somparn P., Kittikowit W., Eiam-Ong S., et al. APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis. Arthritis Res Ther 2012, 14:R252.
66. Panda A.K., Parida J.R., Tripathy R., Pattanaik S.S., Ravindran B., Das B.K. Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther 2012, 14:R218.
67. Madureira Silva M.V., Moscoso-Solorzano G.T., Nishida S.K., Mastroianni-Kirsztajn G. Serum Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis?. Nephron Extra 2012, 2:169-176.
68. Wang F.M., Yu F., Tan Y., Song D., Zhao M.H. Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis. Rheumatology (Oxford) 2012, 51:2269-2277.
69. Badot V., Luijten R.K., van Roon J.A., Depresseux G., Aydin S., Van den Eynde B.J., et al. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus. Ann Rheum Dis 2013, 72:453-456.
70. Sanchez-Munoz F., Amezcua-Guerra L.M., Macias-Palacios M., Marquez-Velasco R., Bojalil R. Vanin-1 as a potential novel biomarker for active nephritis in systemic lupus erythematosus. Lupus 2013, 22:333-335.
71. Frieri M., Samih M.A., Dzhindzhikhashvili M., Liu H., Balsam L., Rubinstein S. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients. J Nephrol 2012, 25:1041-1046.
72. Menke J., Bork T., Kutska B., Byrne K.T., Blanfeld M., Relle M., et al. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice. Kidney Int 2011, 79:452-463.
73. Eriksson C., Eneslatt K., Ivanoff J., Rantapaa-Dahlqvist S., Sundqvist K.G. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus. Lupus 2003, 12:766-774.
74. Reyes-Thomas J., Blanco I., Putterman C. Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol 2011, 40:138-150.
75. Xie C., Sharma R., Wang H., Zhou X.J., Mohan C. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 2004, 172:5047-5055.
76. Suzuki M., Wiers K., Brooks E.B., Greis K.D., Haines K., Klein-Gitelman M.S., et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009, 65:530-536.
77. Wu T., Xie C., Wang H.W., Zhou X.J., Schwartz N., Calixto S., et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 2007, 179:7166-7175.
78. Rosa R.F., Takei K., Araujo N.C., Loduca S.M., Szajubok J.C., Chahade W.H. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 2012, 39:1948-1954.
79. Hanaoka M., Gono T., Kawaguchi Y., Uchida K., Koseki Y., Katsumata Y., et al. Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology (Oxford) 2013, 10.1093/rheumatology/ket108.
80. Xuejing Z., Jiazhen T., Jun L., Xiangqing X., Shuguang Y., Fuyou L. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol 2012, 2012:359647.
81. Rovin B.H., Birmingham D.J., Nagaraja H.N., Yu C.Y., Hebert L.A. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis 2007, 65:187-193.